Oligonucleotide conjugates
CA 2440322 C · Owner: Geron Corporation · Inventors: Morin, Gregg B.; Pongracz, Krisztina; Tolman, Richard L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Oligonucleotide conjugates, where an oligonucleotide is covalently attached to an aromatic system are provided. In particular embodiments the , oligonucleotide, complementary to the RNA component of telomerase is attached , to a fluorophore. The conjugates inhibit telomerase enzyme activity.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 21, 2002 and granted September 9, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 21, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 21, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.